Information Journal Paper
APA:
Copy. (2022). Oral Nirmatrelvir/ Ritonavir Therapy for COVID-19: The Dawn in the Dark?. Antibiotics (Basel), 11(2), 0-0. SID. https://sid.ir/paper/1114679/en
Vancouver:
Copy. Oral Nirmatrelvir/ Ritonavir Therapy for COVID-19: The Dawn in the Dark?. Antibiotics (Basel)[Internet]. 2022;11(2):0-0. Available from: https://sid.ir/paper/1114679/en
IEEE:
Copy, “Oral Nirmatrelvir/ Ritonavir Therapy for COVID-19: The Dawn in the Dark?,” Antibiotics (Basel), vol. 11, no. 2, pp. 0–0, 2022, [Online]. Available: https://sid.ir/paper/1114679/en